News

FDA warns against laparoscopic power morcellation

Publish date: November 24, 2014

 

References

--Elizabeth Mechcatie contributed to this article.


dchitnis@frontlinemedcom.com

*This article was updated November 24, 2014.

Pages

Recommended Reading

Preop risk assessment, prophylaxis for VTE
MDedge Hematology and Oncology
Bevacizumab plus fosbretabulin improves PFS* in ovarian cancer
MDedge Hematology and Oncology
Racial, geographic, insurance disparities in endometrial cancer outcomes
MDedge Hematology and Oncology
HPV vaccine rates perpetuate racial and geographic cancer disparities
MDedge Hematology and Oncology
No recurrence of cervical cancer seen with simple trachelectomy
MDedge Hematology and Oncology
Salpingectomy associated with reduced ovarian cancer risk
MDedge Hematology and Oncology
Pap testing much less likely in women without regular provider
MDedge Hematology and Oncology
FDA approves bevacizumab for ovarian cancer, with chemotherapy
MDedge Hematology and Oncology
Patient-led follow-up safe and cost effective
MDedge Hematology and Oncology
Bariatric surgery an opportunity to screen for endometrial cancer
MDedge Hematology and Oncology